Thinking of joining a study?

Register your interest

Become a volunteer?

NCT07090200 | RECRUITING | Respiratory Diseases

Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases
Sponsor:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Information provided by (Responsible Party):

Yang Jin

Brief Summary:

Firstly, to screen out the high-risk population of COPD combined with cardiovascular and cerebrovascular diseases, COPD with cardiovascular and make a diagnosis. Then, to evaluate the therapeutic effect of Pulmonary rehabilitation exercise and usual care for three months. And finally, to build a trinity model of rehabilitation management of COPD patients. The objective of this project is to establish and promote the application of diagnostic and treatment norms.

Condition or disease

Respiratory Diseases

Cardiovascular Diseases

Cerebrovascular Diseases

Intervention/treatment

Pulmonary Rehabilitation Care Group

The Routine Care (Non-Pharmacological and Pharmacological Treatments ) Group

Phase

NA

Detailed Description:

Firstly, to screen out the high-risk population of COPD combined with cardiovascular and cerebrovascular diseases, COPD with cardiovascular and make a diagnosis. Then, participants were randomized (1:1) to either the optimized or routine group via a computer-generated random number table. The Routine Care Group received treatment for three months and follow-up with medications prescribed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 Report. The Pulmonary Rehabilitation Care Group received the Pulmonary rehabilitation exercise and usual care for three months. Next, Observe the changes in the improvement of acute exacerbation frequency (times/year/person)，CAT Scoring and St. George's Respiratory Questionnaire (SGRQ), as well as lung ventilation and diffusion function of the two groups of patients one year after the intervention. And finally, to build a trinity model of rehabilitation management of COPD patients.

Study Type : INTERVENTIONAL
Estimated Enrollment : 50000 participants
Masking : NONE
Primary Purpose : OTHER
Official Title : Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases
Actual Study Start Date : 2025-09-01
Estimated Primary Completion Date : 2028-07-31
Estimated Study Completion Date : 2028-07-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • 1. Committed to adhering to the study protocol and cooperating with the implementation of the entire research process.
  • 2. Aged 18 years or older, regardless of gender.
  • 3. Signed informed consent form.
Exclusion Criteria
  • 1. Individuals with severe mental illness.
  • 2. Individuals assessed by medical personnel as having a disease that requires immediate hospitalization or a severe, uncontrollable condition that is life-threatening in the short term.
  • 3. Women who are pregnant, breastfeeding, or using inappropriate contraception methods.
  • 4. Individuals who refuse to cooperate with follow-up questionnaires or specimen collection.
  • 5. Patients currently participating in other interventional clinical drug trials.
Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases

Location Details

NCT07090200

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

China, Hubei

Union hospital, Tongji Medical college, Huazhong University of Science and Technology

Wuhan, Hubei, China, 430022